BUFFALO, NY - Roswell Park Comprehensive Cancer Center has licensed its photodynamic therapy (PDT) technology to pharmaceutical companies in India and China, reports Richard Matner, PhD, MBA, Director of Roswell Park's Technology Transfer Office.

Event focuses on family members, teachers, and school personnel

BUFFALO, NY – Roswell Park Comprehensive Cancer Center will host the third annual Dr. Enrico Mihich lecture series on Wednesday, October 14, at 8 am in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main Roswell Park campus.

BUFFALO, NY - Roswell Park Comprehensive Cancer Center will host a workshop on translational research on Tuesday, November 3, from 8am to 4:30pm in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main Roswell Park campus.

Buffalo, NY - Roswell Park Comprehensive Cancer Center has been awarded a $1.8 million National Institutes of Health (NIH) grant to study new therapeutic approaches for treating B-cell non-Hodgkin's lymphoma (B-NHL).

Buffalo, NY - Roswell Park Comprehensive Cancer Center appointed John Kasznica, MD to the department of Pathology. Dr.

BUFFALO, NY - Breast cancer therapy that's customized for each patient's personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Comprehensive Cancer Center.

An increasing number of women diagnosed with cancer in one breast are opting to have their healthy breast surgically removed, according to a recent study of New York State data.

Study will focus on high versus low-income countries